For help on how to get the results you want, see our search tips.
353 results
Keyword Remove keyword
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Maximum residue limits Remove Maximum residue limits filter
Authorisation status
Withdrawn Remove Withdrawn filter
-
List item
Human medicine European public assessment report (EPAR): Bondenza (previously Ibandronic Acid Roche)
ibandronic acid, Osteoporosis, Postmenopausal
Date of authorisation: 23/02/2004, Revision: 16, Withdrawn, Last updated: 13/05/2013 -
List item
Veterinary medicine European public assessment report (EPAR): Bovalto Ibraxion
inactivated IBR virus, Cattle
Date of authorisation: 09/03/2000, Revision: 10, Withdrawn, Last updated: 13/08/2019 -
List item
Veterinary medicine European public assessment report (EPAR): Bovilis BTV8
bluetongue virus vaccine, serotype 8 (inactivated), Sheep; Cattle
Date of authorisation: 06/09/2010, Revision: 4, Withdrawn, Last updated: 27/07/2022 -
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR AlSap 1
bluetongue-virus serotype-1 antigen, Sheep; Cattle
Date of authorisation: 17/12/2010, Revision: 4, Withdrawn, Last updated: 17/05/2018 -
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR AlSap 2-4
bluetongue-virus serotype-2 antigen, bluetongue-virus serotype-4 antigen, Sheep
Date of authorisation: 04/11/2010, Revision: 4, Withdrawn, Last updated: 13/11/2018 -
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR Alsap 8
bluetongue virus serotype 8 antigen, Sheep; Cattle
Date of authorisation: 17/03/2009, Revision: 5, Withdrawn, Last updated: 16/05/2018 -
List item
Human medicine European public assessment report (EPAR): Budesonide/Formoterol Teva
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 19/11/2014, Revision: 2, Withdrawn, Last updated: 31/01/2017 -
List item
Human medicine European public assessment report (EPAR): Budesonide/Formoterol Teva Pharma B.V.
budesonide, formoterol, Asthma
Date of authorisation: 19/11/2014, Revision: 1, Withdrawn, Last updated: 30/01/2017 -
List item
Human medicine European public assessment report (EPAR): Busilvex (updated)
busulfan, Hematopoietic Stem Cell Transplantation
Date of authorisation: 09/07/2003, Revision: 20, Withdrawn, Last updated: 27/01/2023 -
List item
Human medicine European public assessment report (EPAR): Capecitabine SUN
capecitabine, Stomach Neoplasms; Breast Neoplasms; Colonic Neoplasms; Colorectal Neoplasms
Date of authorisation: 21/06/2013,
, Revision: 3, Withdrawn, Last updated: 22/12/2016
-
List item
Human medicine European public assessment report (EPAR): Caspofungin Accord
caspofungin acetate, Candidiasis; Aspergillosis
Date of authorisation: 11/02/2016,, Revision: 6, Withdrawn, Last updated: 20/08/2021
-
List item
Human medicine European public assessment report (EPAR): CEA-Scan
arcitumomab, Radionuclide Imaging; Colorectal Neoplasms
Date of authorisation: 04/10/1996, Revision: 6, Withdrawn, Last updated: 16/11/2005 -
List item
Human medicine European public assessment report (EPAR): Celvapan
Whole virion influenza vaccine, inactivated containing antigen of strain A/California/07/2009 (H1N1)v, Disease Outbreaks; Influenza, Human; Immunization
Date of authorisation: 04/03/2009, Revision: 11, Withdrawn, Last updated: 21/12/2016 -
List item
Veterinary medicine European public assessment report (EPAR): Certifect
fipronil, amitraz, (S)-methoprene, Dogs
Date of authorisation: 06/05/2011, Revision: 5, Withdrawn, Last updated: 27/07/2018 -
List item
Human medicine European public assessment report (EPAR): ChondroCelect
characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins, Cartilage Diseases
Date of authorisation: 05/10/2009, Revision: 6, Withdrawn, Last updated: 12/01/2017 -
List item
Human medicine European public assessment report (EPAR): Clopidogrel 1A Pharma
clopidogrel, Peripheral Vascular Diseases
Date of authorisation: 28/07/2009,, Revision: 1, Withdrawn, Last updated: 28/02/2011
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,, Revision: 6, Withdrawn, Last updated: 04/01/2018
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino Pharma
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 1, Withdrawn, Last updated: 26/07/2012
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino Pharma GmbH
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 1, Withdrawn, Last updated: 26/07/2012
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel BMS
clopidogrel (as hydrogen sulfate), Stroke; Peripheral Vascular Diseases; Myocardial Infarction; Acute Coronary Syndrome
Date of authorisation: 16/07/2008, Revision: 3, Withdrawn, Last updated: 26/01/2010 -
List item
Human medicine European public assessment report (EPAR): Clopidogrel DURA
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/07/2009,, Revision: 6, Withdrawn, Last updated: 10/07/2015
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Hexal
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,, Revision: 2, Withdrawn, Last updated: 26/07/2012
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Qualimed
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 4, Withdrawn, Last updated: 08/09/2014
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 5, Withdrawn, Last updated: 12/12/2013
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH
clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009,, Revision: 12, Withdrawn, Last updated: 25/01/2021